Molnupiravir Demonstrates No Benefit In Patients With Symptomatic COVID-19 Infection, Research Suggests

Infectious Disease Advisor (7/11, Barowski) reports, “Although molnupiravir was not found to be associated with an overall reduction in hospitalization or 30-day mortality in patients with COVID-19 infection, it was beneficial among those who were asympto...